Hubert Chen
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Hubert Chen is Chief Medical Officer at Attovia Therapeutics, Inc. since 2024.
Former positions include Medical Director at Genentech, Inc. and Senior Vice President-Clinical Development at Krystal Biotech, Inc. Education includes graduate studies at Harvard University and a doctorate from Stanford University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-08-2026 | 2.960 ( 0,01% ) | 0 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 01-03-2024 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau